NDA 18173, held by Pharmacia And Upjohn. Cyclothiazide.
As of Nov 13, 2026, NDA 18173 (Fluidil), held by Pharmacia And Upjohn, was not approved, with 2 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Fluidil2MG · tablet;oral | Cyclothiazide | Discontinued |
| Sep 13, 1983 | Supplement 3Manufacturing · Standard review | Approved | None posted |
| Jun 8, 1982 | Supplement 1Manufacturing · Standard review | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters